-
Save the Date – FARA and Reata Webinar
On January 5th at 7 pm (EST) is a FARA Webinar: FA Community Call to Action!
This webinar will outline FARA’s proposed response from the FA Community to the positive results of Reata Pharmaceuticals’ MOXIe Part 2 clinical study.
After consulting with industry partners, FARA is planning on sending Reata and the Food and Drug Administration (FDA) a letter that requests they work together to provide access to omavloxolone to FA patients as soon as possible. It is crucial that our response is respectful, informative, and representative of the FA patient experience.
To register and learn how you can participate click here: https://myemail.constantcontact.com/Save-the-Date–January-5–2021—Webinar–FA-Community-Call-to-Action—Be-a-Part-of-the-FA-Community-s-Request-for-Access-to-Re.html?soid=1101190303489&aid=dwijdGfQOG4
-
1 Reply
-
Hope something good comes of this 🙂
Log in to reply.